Abstract
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms that require a
multidisciplinary process to determine the most appropriate approach for patient management
and therapy. Over time, the treatment algorithms have continuously evolved as the
options have improved and changed. This manuscript reviews the current and potential
role of image-guided ablation in the treatment of patients with metastatic NET to
the liver. While some attention will be devoted to the basics of ablation, the focus
will be on the role of image-guided ablation in these patients and issues specific
to the treatment of NET's liver metastases with ablation.
Keywords
ablation - neuroendocrine tumor - symptoms
